United Therapeutics
UTHR
$225.87
Share price
-0.07%
Change (1 day)
-1.16%
Change (1 year)
Categories
United Therapeutics (UTHR) - Net assets
Net assets on the balance sheet as of June 2023 : $5.41 B
According to United Therapeutics's latest financial reports the company has $5.41 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
United Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $4.79 B | 21.16% |
| 2021-12-31 | $3.95 B | 16.6% |
| 2020-12-31 | $3.39 B | 22.11% |
| 2019-12-31 | $2.78 B | -0.29% |
| 2018-12-31 | $2.78 B | 32.68% |
| 2017-12-31 | $2.10 B | 12.87% |
| 2016-12-31 | $1.86 B | 16.41% |
| 2015-12-31 | $1.59 B | 26.4% |
| 2014-12-31 | $1.26 B | -2.97% |
| 2013-12-31 | $1.30 B | 19.13% |
| 2012-12-31 | $1.09 B | 15.43% |
| 2011-12-31 | $0.94 B | 7.31% |
| 2010-12-31 | $0.88 B | 35.36% |
| 2009-12-31 | $0.65 B | 28.62% |
| 2008-12-31 | $0.50 B | 71.64% |
| 2007-12-31 | $0.29 B | 44.57% |
| 2006-12-31 | $0.20 B | -25.63% |
| 2005-12-31 | $0.27 B | 43.55% |
| 2004-12-31 | $0.19 B | 14.23% |
| 2003-12-31 | $0.16 B | -2.27% |
| 2002-12-31 | $0.17 B | -12.6% |
| 2001-12-31 | $0.19 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $101.23 B | 1,770.93% | 🇺🇸 USA |
 Eli Lilly LLY | $11.14 B | 106.05% | 🇺🇸 USA |
 Baxter BAX | $5.63 B | 4.07% | 🇺🇸 USA |
 Gilead Sciences GILD | $21.09 B | 289.84% | 🇺🇸 USA |
 Cardinal Health CAH | -$2.86 B | -152.69% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.33 B | 183.46% | 🇬🇧 UK |
 Cytokinetics
CYTK | -$0.34 B | -106.16% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $7.70 B | 42.45% | 🇮🇱 Israel |